Immune shareholders to receive additional pro rata shares in Cytovia Immune Pharmaceuticals NASDAQ IMNP Immune today confirmed it is continuing to structure and pursue a spinoff of Cytovia Inc. Cytovia its subsidiary dedicated to...
↧